Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

WDR47 Inhibitors

WDR47 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the WDR47 protein, a member of the WD repeat-containing protein family. This family of proteins is characterized by the presence of multiple WD40 repeat domains, which play a pivotal role in facilitating protein-protein interactions and the assembly of multiprotein complexes. WDR47 is involved in various cellular processes, including signal transduction, intracellular trafficking, and cytoskeletal organization. It is particularly significant in neural cells, where it contributes to the regulation of neuronal development, axonal transport, and synaptic function. By inhibiting WDR47, these compounds disrupt its ability to interact with other proteins, leading to the modification of key cellular processes, particularly those related to cell structure and communication.

The mechanism of action of WDR47 inhibitors typically involves binding to the WD40 repeat domains or other functional regions of the protein, thereby preventing WDR47 from forming essential protein complexes. This interference alters several cellular pathways, including those involved in cytoskeletal dynamics, vesicle transport, and protein localization within cells. WDR47 inhibitors are valuable research tools used to study the role of this protein in maintaining cellular organization and supporting proper cell signaling. By blocking WDR47 activity, researchers can investigate its specific contributions to various biological functions, particularly in the context of neural cells, where WDR47 plays a critical role. These inhibitors provide insight into how the disruption of WDR47 affects broader cellular networks, allowing scientists to explore the importance of protein interactions mediated by WD repeat-containing proteins in cellular homeostasis and regulation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Interferes with autophagosome fusion with lysosomes, potentially influencing WDR47 activity within this pathway.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$56.00
$256.00
113
(3)

Inhibits class III PI3K, disrupting early stages of autophagosome formation, which can indirectly affect WDR47 function.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Inhibitor of the fusion between autophagosomes and lysosomes, which can influence WDR47 activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor that can block autophagy induction, potentially affecting WDR47.

Spautin-1

1262888-28-7sc-507306
10 mg
$165.00
(0)

Targets ubiquitin-specific peptidases, impairing autophagy, thereby indirectly influencing WDR47.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A broad-spectrum PI3K inhibitor that can affect autophagy and thereby WDR47 function.

hydroxychloroquine

118-42-3sc-507426
5 g
$56.00
1
(0)

Modifies endosomal pH, preventing fusion of autophagosomes with lysosomes, potentially influencing WDR47.

Lys05

1391426-24-6sc-507532
5 mg
$140.00
(0)

Inhibits lysosomal function, impairing autophagy and possibly WDR47 activity.

SAR405

1523406-39-4sc-507416
1 mg
$125.00
(0)

PIK3C3/VPS34 inhibitor that can impede autophagy initiation, thereby affecting WDR47.

SBI-0206965

1884220-36-3sc-507431
10 mg
$122.00
(0)

Targets ULK1, a protein critical for autophagy initiation, which can affect WDR47.